(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are IDEX BIOMETRICS, TERACT, and BIOSENIC.

Financial Asset	Price	Change	Updated (EST)
IDEX BIOMETRICS (IDEX.OL)	2.50	41.85%	2024-03-20 12:40:41
TERACT (TRACT.PA)	0.89	13.23%	2024-03-20 13:24:27
BIOSENIC (BIOS.BR)	0.02	10.81%	2024-03-20 12:06:26
AUGROS COSMETICS (AUGR.PA)	6.80	10.57%	2024-03-20 12:47:24
CTT CORREIOS PORT (CTT.LS)	3.91	9.37%	2024-03-20 12:23:50
HYBRID SOFTWARE GR (HYSG.BR)	3.28	7.89%	2024-03-20 12:20:11
BENETEAU (BEN.PA)	13.66	7.22%	2024-03-20 13:00:23
FOUNTAIN (FOU.BR)	1.29	6.61%	2024-03-20 12:07:36
ADC SIIC (ALDV.PA)	0.07	6.43%	2024-03-20 12:46:04
ERAMET (ERA.PA)	68.25	6.39%	2024-03-20 13:03:19

The three biggest losers today are KERING, VALNEVA, and EBUSCO HOLDING.

Financial Asset	Price	Change	Updated (EST)
KERING (KER.PA)	367.15	-13.8%	2024-03-20 13:06:43
VALNEVA (VLA.PA)	3.36	-11.08%	2024-03-20 13:25:23
EBUSCO HOLDING (EBUS.AS)	3.35	-8.47%	2024-03-20 12:02:03
GUERBET (GBT.PA)	29.35	-7.12%	2024-03-20 13:05:45
EURONAV (EURN.BR)	13.22	-7%	2024-03-20 12:07:22
ENVIPCO (ENVI.AS)	5.45	-6.84%	2024-03-20 12:02:12
POLIGHT (PLT.OL)	3.71	-6.44%	2024-03-20 12:42:52
VOW (VOW.OL)	6.44	-5.99%	2024-03-20 12:45:10
VETOQUINOL (VETO.PA)	97.10	-5.73%	2024-03-20 13:25:37
CFI (CFI.PA)	0.51	-5.56%	2024-03-20 13:01:19

Winners today

1. IDEX BIOMETRICS (IDEX.OL)

41.85% Price Change

IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. The company was incorporated in 1996 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS rising 41.85% to €2.50 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.06% to €1,303.74, after three consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-1.06.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -155.84%.

More news about IDEX BIOMETRICS.

2. TERACT (TRACT.PA)

13.23% Price Change

Teract S.A. operates in retail business in Europe. The company operates through Garden Centre Retailer and Marketer segments. It operates garden centers and pet care shops under the Jardiland, Gamm vert, Delbard, and Jardinerie du Terroir brand names. The company also operates in the fresh, local, and organic produce sector under Frais d'Ici and Bio&Co brands with food outlets. It operates 1,597 stores. The company is based in Paris, France.

CAC 40 ended the session with TERACT rising 13.23% to €0.89 on Wednesday while CAC 40 dropped 0.48% to €8,161.41.

Earnings Per Share

As for profitability, TERACT has a trailing twelve months EPS of €0.62.

PE Ratio

TERACT has a trailing twelve months price to earnings ratio of 1.44. Meaning, the purchaser of the share is investing €1.44 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.98%.

Volume

Today’s last reported volume for TERACT is 62604 which is 28.16% above its average volume of 48845.

Moving Average

TERACT’s value is way under its 50-day moving average of €2.60 and way under its 200-day moving average of €4.40.

More news about TERACT.

3. BIOSENIC (BIOS.BR)

10.81% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC rising 10.81% to €0.02 on Wednesday while BEL 20 rose 0.12% to €3,685.41.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €7.53.

Volatility

BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.92%, a negative 1.77%, and a positive 5.38%.

BIOSENIC’s highest amplitude of average volatility was 5.92% (last week), 4.46% (last month), and 5.38% (last quarter).

More news about BIOSENIC.

4. AUGROS COSMETICS (AUGR.PA)

10.57% Price Change

Augros Cosmetic Packaging SA provides customized packaging solutions in France. The company offers decoration solutions for glass, plastic, and aluminum packaging materials. It serves the perfume, cosmetic, and spirit industries. The company is based in Alencon, France. Augros Cosmetic Packaging SA operates as a subsidiary of Famille Bourgine.

CAC 40 ended the session with AUGROS COSMETICS rising 10.57% to €6.80 on Wednesday while CAC 40 fell 0.48% to €8,161.41.

Earnings Per Share

As for profitability, AUGROS COSMETICS has a trailing twelve months EPS of €0.43.

PE Ratio

AUGROS COSMETICS has a trailing twelve months price to earnings ratio of 15.81. Meaning, the purchaser of the share is investing €15.81 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AUGROS COSMETICS’s stock is considered to be overbought (>=80).

More news about AUGROS COSMETICS.

5. CTT CORREIOS PORT (CTT.LS)

9.37% Price Change

CTT – Correios De Portugal, S.A., together with its subsidiaries, provides postal and financial services worldwide. It operates through Mail, Express & Parcels, Financial Services & Retail, and Bank segments. The company offers courier and urgent mail transport services; postal financial services; and banking services. It also engages in the business of payments related to collection of invoices and fines. In addition, the company enables the payment of various services and utilities through a network of approximately 5,000 agents covering business outlets as stationery stores, tobacco shops, kiosks, and supermarkets. It operates a retail network of 566 post offices; 1,808 postal agencies; 223 postal delivery offices; 4,576 postal delivery routes; and a fleet of 3,925 vehicles. The company was formerly known as Correio Publico. CTT – Correios De Portugal, S.A. was founded in 1520 and is headquartered in Lisbon, Portugal.

PSI ended the session with CTT CORREIOS PORT jumping 9.37% to €3.91 on Wednesday, following the last session’s upward trend. PSI rose 0.48% to €6,152.21, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, CTT CORREIOS PORT has a trailing twelve months EPS of €0.31.

PE Ratio

CTT CORREIOS PORT has a trailing twelve months price to earnings ratio of 12.61. Meaning, the purchaser of the share is investing €12.61 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.89%.

Yearly Top and Bottom Value

CTT CORREIOS PORT’s stock is valued at €3.91 at 21:40 EST, above its 52-week high of €3.81.

Moving Average

CTT CORREIOS PORT’s worth is above its 50-day moving average of €3.64 and way higher than its 200-day moving average of €3.52.

Sales Growth

CTT CORREIOS PORT’s sales growth is 0.3% for the current quarter and 12.7% for the next.

More news about CTT CORREIOS PORT.

6. HYBRID SOFTWARE GR (HYSG.BR)

7.89% Price Change

Hybrid Software Group PLC, together with its subsidiaries, develops software and hardware technology solutions for graphics and industrial inkjet printing in the United Kingdom, rest of Europe, North and South America, and Asia. The company offers Harlequin Core, a raster image processor (RIP) software that converts text and image data from various file formats, including PDF, TIFF, and JPEG files; ScreenPro, a software that converts tone image data into ready-to-print halftone in real-time; and Mako SDK, a software that creates, rasterizes, converts, analyses, and optimizes various page description languages, as well as allows print software developers to control over colour, fonts, text, images, vector content, and metadata. It also provides Harlequin Direct, a software that drives print data directly to the printer electronics instead of buffering them on mass storage devices; SmartDFE, a turnkey digital front end based on Harlequin Direct, CLOUDFLOW, and Meteor for digital printing of labels and packaging; Navigator Harlequin RIP and Workflow, a software that offers prepress environments to interpretation of PostScript, PDF, and EPS format files; Navigator DFE, a software that helps to prepare jobs, manage colour, and control digital output devices built with Memjet or any standard inkjet printhead; and Output Device Interfaces, a hardware and software solutions to connect RIPs to computer-to-plate devices, imagesetters, proofers, digital presses, high-speed copiers, and inkjet printers. The company was formerly known as Global Graphics PLC and changed its name to Hybrid Software Group PLC in October 2021. Hybrid Software Group PLC was founded in 1986 and is headquartered in Cambridge, the United Kingdom.

BEL 20 ended the session with HYBRID SOFTWARE GR rising 7.89% to €3.28 on Wednesday, after two sequential sessions in a row of losses. BEL 20 rose 0.12% to €3,685.41, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, HYBRID SOFTWARE GR has a trailing twelve months EPS of €0.02.

PE Ratio

HYBRID SOFTWARE GR has a trailing twelve months price to earnings ratio of 164. Meaning, the purchaser of the share is investing €164 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.54%.

Volatility

HYBRID SOFTWARE GR’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.24%, a negative 0.11%, and a positive 2.36%.

HYBRID SOFTWARE GR’s highest amplitude of average volatility was 2.93% (last week), 2.84% (last month), and 2.36% (last quarter).

More news about HYBRID SOFTWARE GR.

7. BENETEAU (BEN.PA)

7.22% Price Change

Bénéteau S.A. designs, manufactures, and sells boats and leisure homes in France and internationally. It provides boats under the Beneteau, Jeanneau, Lagoon, Prestige, Four Winns, Scarab, WellCraft, EXCESS, and Delphia brand names; and leisure homes under the IRM, O'HARA, and Coco Sweet brand names. The company also offers bandofbaots.com, a community services platform for purchase and sale of new or used boats; lease purchase, credit, and insurance services through SGB Finance; and inventory and retail finance solutions. Bénéteau S.A. was founded in 1884 and is headquartered in Saint Gilles Croix de Vie, France. Bénéteau S.A. operates as a subsidiary of BERI 21 S.A.

CAC 40 ended the session with BENETEAU jumping 7.22% to €13.66 on Wednesday while CAC 40 dropped 0.48% to €8,161.41.

Earnings Per Share

As for profitability, BENETEAU has a trailing twelve months EPS of €2.21.

PE Ratio

BENETEAU has a trailing twelve months price to earnings ratio of 6.18. Meaning, the purchaser of the share is investing €6.18 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.43%.

Yearly Top and Bottom Value

BENETEAU’s stock is valued at €13.66 at 21:40 EST, way under its 52-week high of €17.38 and way higher than its 52-week low of €10.52.

More news about BENETEAU.

8. FOUNTAIN (FOU.BR)

6.61% Price Change

Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in in France, Belgium, the Netherlands, and rest of European Countries. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was incorporated in 1972 and is based in Braine l'Alleud, Belgium.

BEL 20 ended the session with FOUNTAIN rising 6.61% to €1.29 on Wednesday while BEL 20 rose 0.12% to €3,685.41.

Earnings Per Share

As for profitability, FOUNTAIN has a trailing twelve months EPS of €-0.11.

Volatility

FOUNTAIN’s last week, last month’s, and last quarter’s current intraday variation average was 0.43%, 0.43%, and 5.02%.

FOUNTAIN’s highest amplitude of average volatility was 3.88% (last week), 3.88% (last month), and 5.02% (last quarter).

More news about FOUNTAIN.

9. ADC SIIC (ALDV.PA)

6.43% Price Change

Alliance Developpement Capital SIIC (ADC SIIC) is a publicly owned real estate investment firm. The firm specializes in owning and managing residential real estate properties. It primarily invests in properties in Paris and its suburbs. The firm was formerly known as AD Capital SA. Alliance Developpement Capital is based in Saint-Josse-Ten-Noode, Belgium.

CAC 40 ended the session with ADC SIIC jumping 6.43% to €0.07 on Wednesday while CAC 40 slid 0.48% to €8,161.41.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.45%.

More news about ADC SIIC.

10. ERAMET (ERA.PA)

6.39% Price Change

ERAMET S.A. operates as a mining and metallurgical company in France, Asia, Europe, North America, and internationally. The company extracts and processes manganese ore and nickel ore; and extracts and develops mineral sands. It also produces ferronickel, nickel pig iron, briquettes, nickel salts, high purity nickel, nickel ferroalloys, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, pigments, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. In addition, it operates Moanda mine in Gabon; nickel mines in New Caledonia and Indonesia; and mineral sand mine in Senegal and Argentina. ERAMET S.A. was incorporated in 1880 and is headquartered in Paris, France.

CAC 40 ended the session with ERAMET rising 6.39% to €68.25 on Wednesday while CAC 40 fell 0.48% to €8,161.41.

Earnings Per Share

As for profitability, ERAMET has a trailing twelve months EPS of €3.58.

PE Ratio

ERAMET has a trailing twelve months price to earnings ratio of 19.06. Meaning, the purchaser of the share is investing €19.06 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.57%.

Moving Average

ERAMET’s worth is higher than its 50-day moving average of €63.74 and under its 200-day moving average of €71.52.

Revenue Growth

Year-on-year quarterly revenue growth declined by 30.9%, now sitting on 3.34B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ERAMET’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for ERAMET is 71008 which is 62.24% above its average volume of 43766.

More news about ERAMET.

Losers Today

1. KERING (KER.PA)

-13.8% Price Change

Kering SA manages the development of a series of renowned houses in fashion, leather goods and jewelry in France, the Asia-Pacific, Western Europe, North America, Japan, and internationally. The company offers ready-to-wear products apparel and accessories for men and women. It also offers leather goods and shoes; watches and jewelry; eyewear products; and fragrances and cosmetics. The company provides Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Brioni, Boucheron, Pomellato, DoDo, Qeelin, Ginori 1735, Kering Beauté, and Kering Eyewear brands. The company was formerly known as PPR SA and changed its name to Kering SA in June 2013. Kering SA was founded in 1963 and is based in Paris, France.

CAC 40 ended the session with KERING falling 13.8% to €367.15 on Wednesday, following the last session’s upward trend. CAC 40 fell 0.48% to €8,161.41, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, KERING has a trailing twelve months EPS of €24.36.

PE Ratio

KERING has a trailing twelve months price to earnings ratio of 15.07. Meaning, the purchaser of the share is investing €15.07 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.04%.

Volatility

KERING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.14%, a negative 0.03%, and a positive 1.18%.

KERING’s highest amplitude of average volatility was 0.46% (last week), 0.85% (last month), and 1.18% (last quarter).

Volume

Today’s last reported volume for KERING is 757838 which is 263.22% above its average volume of 208640.

Sales Growth

KERING’s sales growth is 5.4% for the present quarter and 10.6% for the next.

More news about KERING.

2. VALNEVA (VLA.PA)

-11.08% Price Change

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.

CAC 40 ended the session with VALNEVA sliding 11.08% to €3.36 on Wednesday while CAC 40 dropped 0.48% to €8,161.41.

Earnings Per Share

As for profitability, VALNEVA has a trailing twelve months EPS of €-0.82.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.81%.

Sales Growth

VALNEVA’s sales growth is negative 76.3% for the ongoing quarter and negative 58.9% for the next.

More news about VALNEVA.

3. EBUSCO HOLDING (EBUS.AS)

-8.47% Price Change

Ebusco Holding N.V., together with its subsidiaries, develops, manufactures, and distributes zero emission buses, batteries, and charging systems in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. It also sells ancillary products and services; and provides electric vehicle ecosystem repair and maintenance services. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.

AEX-Index ended the session with EBUSCO HOLDING sliding 8.47% to €3.35 on Wednesday while AEX-Index fell 0.02% to €860.54.

Earnings Per Share

As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-0.9.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.25%.

Volatility

EBUSCO HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was 4.78%, 0.28%, and 2.78%.

EBUSCO HOLDING’s highest amplitude of average volatility was 9.15% (last week), 4.26% (last month), and 2.78% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EBUSCO HOLDING’s stock is considered to be oversold (<=20).

Moving Average

EBUSCO HOLDING’s worth is below its 50-day moving average of €3.70 and way under its 200-day moving average of €5.91.

Yearly Top and Bottom Value

EBUSCO HOLDING’s stock is valued at €3.35 at 21:40 EST, way under its 52-week high of €10.71 and way above its 52-week low of €2.80.

More news about EBUSCO HOLDING.

4. GUERBET (GBT.PA)

-7.12% Price Change

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was incorporated in 1926 and is headquartered in Villepinte, France.

CAC 40 ended the session with GUERBET sliding 7.12% to €29.35 on Wednesday while CAC 40 fell 0.48% to €8,161.41.

Earnings Per Share

As for profitability, GUERBET has a trailing twelve months EPS of €-3.35.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.79%.

Yearly Top and Bottom Value

GUERBET’s stock is valued at €29.35 at 21:40 EST, way above its 52-week high of €23.20.

Moving Average

GUERBET’s value is way above its 50-day moving average of €18.76 and way above its 200-day moving average of €18.37.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.5%, now sitting on 775.1M for the twelve trailing months.

More news about GUERBET.

5. EURONAV (EURN.BR)

-7% Price Change

Euronav NV, together with its subsidiaries, engages in the transportation and storage of crude oil worldwide. The company offers floating, storage, and offloading (FSO) services. It also owns and operates a fleet of vessels. The company was incorporated in 2003 and is headquartered in Antwerp, Belgium.

BEL 20 ended the session with EURONAV sliding 7% to €13.22 on Wednesday while BEL 20 jumped 0.12% to €3,685.41.

Earnings Per Share

As for profitability, EURONAV has a trailing twelve months EPS of €3.93.

PE Ratio

EURONAV has a trailing twelve months price to earnings ratio of 3.36. Meaning, the purchaser of the share is investing €3.36 for every euro of annual earnings.

Volume

Today’s last reported volume for EURONAV is 311242 which is 132.54% above its average volume of 133840.

More news about EURONAV.

6. ENVIPCO (ENVI.AS)

-6.84% Price Change

Envipco Holding N.V., together with its subsidiaries, designs, develops, manufactures, and sells or leases reverse vending machines (RVM) for the collection and processing of used beverage containers primarily in the Netherlands, North America, and Europe. The company provides technical support, RVM maintenance, and accounting services to the retail stores, bottlers, and distributors for containers redeemed through its machines. It also offers deposit, handling fees, scrap reconciliations, commodity brokerage, clearing house functions, and accounting services. In addition, the company provides materials handling services primarily in the northeastern part of the United States. Envipco Holding N.V. was incorporated in 1998 and is headquartered in Amersfoort, the Netherlands.

AEX-Index ended the session with ENVIPCO sliding 6.84% to €5.45 on Wednesday while AEX-Index fell 0.02% to €860.54.

Earnings Per Share

As for profitability, ENVIPCO has a trailing twelve months EPS of €-0.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.02%.

Volatility

ENVIPCO’s last week, last month’s, and last quarter’s current intraday variation average was 5.21%, 2.91%, and 4.02%.

ENVIPCO’s highest amplitude of average volatility was 8.20% (last week), 5.31% (last month), and 4.02% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 221.3% and 212.7%, respectively.

More news about ENVIPCO.

7. POLIGHT (PLT.OL)

-6.44% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; ASIC drivers, which control the supply of variable voltage to Tlens products and makes them to change focus; TLens Silver and TLens Silver Premium devices; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. it serves smartphones and wearables, barcode/industrial, augmented reality, medical endoscopy, webcams, and other markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT sliding 6.44% to €3.71 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.06% to €1,303.74, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 22.51M for the twelve trailing months.

Volume

Today’s last reported volume for POLIGHT is 348621 which is 60.53% below its average volume of 883431.

Volatility

POLIGHT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 17.04%, a negative 7.43%, and a positive 6.60%.

POLIGHT’s highest amplitude of average volatility was 22.35% (last week), 11.03% (last month), and 6.60% (last quarter).

Moving Average

POLIGHT’s worth is way below its 50-day moving average of kr14.18 and way below its 200-day moving average of kr13.69.

More news about POLIGHT.

8. VOW (VOW.OL)

-5.99% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. It operates in three segments: Projects Cruise, Aftersales, and Landbased. The Projects Cruise segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables; chemicals; and tailor-made service and maintenance programs. The Landbased segment offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. This segment also develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. The company serves cruise, aquaculture, and landbased industries, as well as utilities. It has a strategic partnership agreement with Repsol, S.A. to explore applications and solutions to produce clean and renewable energy for CO2 emission reduction; European Tyre Enterprise Ltd. to develop a modularised and industrial solutions, and value chain to turn end-of-life tires into raw material and renewable energy; GRTgaz to produce a demo plant built to confirm that CO2 neutral pyrolysis gas can replace fossil gas in the European gas grid; SAS IMPROVE to develop technological solutions for the farm to fork valorisation of future proteins; and Imtech Steri's Biosteam to offer a range of ingredient sterilisation solutions and services. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW falling 5.99% to €6.44 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.06% to €1,303.74.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr0.05.

PE Ratio

VOW has a trailing twelve months price to earnings ratio of 128.8. Meaning, the purchaser of the share is investing kr128.8 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.1%.

More news about VOW.

9. VETOQUINOL (VETO.PA)

-5.73% Price Change

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

CAC 40 ended the session with VETOQUINOL falling 5.73% to €97.10 on Wednesday while CAC 40 dropped 0.48% to €8,161.41.

Earnings Per Share

As for profitability, VETOQUINOL has a trailing twelve months EPS of €4.97.

PE Ratio

VETOQUINOL has a trailing twelve months price to earnings ratio of 19.54. Meaning, the purchaser of the share is investing €19.54 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.13%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VETOQUINOL’s stock is considered to be overbought (>=80).

More news about VETOQUINOL.

10. CFI (CFI.PA)

-5.56% Price Change

CFI-Compagnie Foncière Internationale, a real estate investment company, engages in leasing land and other property assets. The company was formerly known as Didot-Bottin and changed its name on December 9, 2008. As of December 31, 2009, its real estate portfolio comprised 12 assets located in France. CFI-Compagnie Foncière Internationale was founded in 1796 and is based in Paris, France.

CAC 40 ended the session with CFI falling 5.56% to €0.51 on Wednesday while CAC 40 dropped 0.48% to €8,161.41.

Earnings Per Share

As for profitability, CFI has a trailing twelve months EPS of €-0.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -866.67%.

More news about CFI.

Stay up to date with our winners and losers daily report